Novartis is buying Avidity Biosciences for $12 billion, picking up RNA-based medicines for neuromuscular diseases as it seeks ...
Datavant, the data collaboration platform trusted for healthcare, today announced a planned partnership with athenahealth, Inc., a leading provider of network-enabled software and services for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback